Lars Nieba, PhD
Dr Lars Nieba brings 20 years of leadership experience in the development of multiple pharmaceutical product candidates and innovative technologies. He comes from Bayer AG, where he served as VP and Strategic Product Lead. He joined Bayer in 2016, following 13 years at F. Hoffmann-La Roche Ltd., at which he held leadership roles in clinical supply planning, biologics technology and technical business development biologics. Dr Nieba gained a PhD from the Max-Planck-Institute for Biochemistry, Munich, and Institute for Biochemistry at the University of Zürich; and an Executive MBA from the University of St. Gallen, Switzerland. He joined Nordic Nanovector on 1 December 2019.